Cipla focuses on respiratory therapies, specialty drugs and complex generics
Published on: May 13, 2026, 7:47 p.m. | Source: Business Today
India business crosses ₹12,680 crore in FY26 as Cipla expands specialty pipeline, respiratory portfolio and regulated market presence
